{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:40:50Z","timestamp":1792424450284,"version":"4.5.0"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-06004-2","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T02:56:05Z","timestamp":1792378565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Emerging therapeutic role of cinnamic acid derivatives in hyperuricemia and gout: mechanistic, translational, and pharmacological perspectives"],"prefix":"10.1007","author":[{"given":"Shibanee","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3488-1092","authenticated-orcid":false,"given":"Reetuparna","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchit Suman","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subarna","family":"Mahanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"key":"6004_CR1","unstructured":"Menon SG, Rednam M, Gujarathi R, Maher L (2026) Gout. StatPearls 2026. https:\/\/pubmed.ncbi.nlm.nih.gov\/31536213\/"},{"key":"6004_CR2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/J.CCL.2021.04.009\/ASSET\/64635F92-245F-4284-A82F-76E88F7652B7\/MAIN.ASSETS\/GR1.SML","volume":"39","author":"D Agnoletti","year":"2021","unstructured":"Agnoletti D, Cicero AFG, Borghi C (2021) The impact of uric acid and hyperuricemia on cardiovascular and renal systems. Cardiol Clin 39:365\u2013376. https:\/\/doi.org\/10.1016\/J.CCL.2021.04.009\/ASSET\/64635F92-245F-4284-A82F-76E88F7652B7\/MAIN.ASSETS\/GR1.SML","journal-title":"Cardiol Clin"},{"key":"6004_CR3","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.8685","volume":"18","author":"T Alotaibi","year":"2024","unstructured":"Alotaibi T, Bjazevic J, Kim R, Gryn S, Sultan N, Dresser G et al (2024) Allopurinol hypersensitivity syndrome: raising awareness of an uncommon but potentially serious adverse event among kidney stone patients. Can Urol Assoc J 18:E167. https:\/\/doi.org\/10.5489\/cuaj.8685","journal-title":"Can Urol Assoc J"},{"key":"6004_CR4","doi-asserted-by":"publisher","first-page":"12402","DOI":"10.1007\/S11356-022-22940-X","volume":"30","author":"F Alt\u0131nda\u011f","year":"2023","unstructured":"Alt\u0131nda\u011f F, Ergen H (2023) Sinapic acid alleviates cisplatin-induced acute kidney injury by mitigating oxidative stress and apoptosis. Environ Sci Pollut Res Int 30:12402\u201312411. https:\/\/doi.org\/10.1007\/S11356-022-22940-X","journal-title":"Environ Sci Pollut Res Int"},{"key":"6004_CR5","doi-asserted-by":"publisher","first-page":"1128699","DOI":"10.3389\/FPHAR.2023.1128699\/BIBTEX","volume":"14","author":"MF An","year":"2023","unstructured":"An MF, Shen C, Zhang SS, Wang MY, Sun ZR, Fan MS et al (2023) Anti-hyperuricemia effect of hesperetin is mediated by inhibiting the activity of xanthine oxidase and promoting excretion of uric acid. Front Pharmacol 14:1128699. https:\/\/doi.org\/10.3389\/FPHAR.2023.1128699\/BIBTEX","journal-title":"Front Pharmacol"},{"key":"6004_CR6","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.3390\/MOLECULES29163929\/S1","volume":"29","author":"RM Annuur","year":"2024","unstructured":"Annuur RM, Triana D, Ernawati T, Murai Y, Aswad M, Hashimoto M et al (2024) A review of cinnamic acid\u2019s skeleton modification: features for antibacterial-agent-guided derivatives. Molecules 29:3929. https:\/\/doi.org\/10.3390\/MOLECULES29163929\/S1","journal-title":"Molecules"},{"key":"6004_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/APHA.13980","volume":"238","author":"EA Adomako","year":"2023","unstructured":"Adomako EA, Moe OW (2023) Uric acid transport, transporters, and their pharmacological targeting. Acta Physiol 238:e13980. https:\/\/doi.org\/10.1111\/APHA.13980","journal-title":"Acta Physiol"},{"issue":"1","key":"6004_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12891-024-08180-9","volume":"25","author":"KM Asghari","year":"2024","unstructured":"Asghari KM, Zahmatyar M, Seyedi F, Motamedi A, Zolfi M, Alamdary SJ et al (2024) Gout: global epidemiology, risk factors, comorbidities and complications: a narrative review. BMC Musculoskelet Disord 25(1):1\u201319. https:\/\/doi.org\/10.1186\/S12891-024-08180-9","journal-title":"BMC Musculoskelet Disord"},{"key":"6004_CR9","unstructured":"Aziz N, Jamil RT (2023) Biochemistry, Xanthine oxidase. StatPearls 2023. https:\/\/pubmed.ncbi.nlm.nih.gov\/31424829\/"},{"key":"6004_CR10","doi-asserted-by":"publisher","first-page":"6089","DOI":"10.3390\/JCM12186089\/S1","volume":"12","author":"Y Bai","year":"2023","unstructured":"Bai Y, Wu B, Gou L, Fang Z, Xu T, Zhang T et al (2023) Cardiovascular safety evaluation of febuxostat and allopurinol: findings from the FDA adverse event reporting system. J Clin Med 12:6089. https:\/\/doi.org\/10.3390\/JCM12186089\/S1","journal-title":"J Clin Med"},{"key":"6004_CR11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/WRR.12973;PAGE:STRING:ARTICLE\/CHAPTER","volume":"30","author":"W Bao","year":"2022","unstructured":"Bao W, Xue Y, Cheng X, Wang P, Yin B, Su Y et al (2022) Gout-associated uric acid crystals induce tophi ulcerations and impair wound healing in a novel gouty ulcer model. Wound Repair and Regen 30:132\u2013139. https:\/\/doi.org\/10.1111\/WRR.12973;PAGE:STRING:ARTICLE\/CHAPTER","journal-title":"Wound Repair and Regeneration"},{"issue":"4","key":"6004_CR12","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/S43440-023-00494-0","volume":"75","author":"X Bao","year":"2023","unstructured":"Bao X, Li W, Jia R, Meng D, Zhang H, Xia L (2023) Molecular mechanism of ferulic acid and its derivatives in tumor progression. Pharmacol Rep 75(4):891\u2013906. https:\/\/doi.org\/10.1007\/S43440-023-00494-0","journal-title":"Pharmacol Rep"},{"key":"6004_CR13","unstructured":"Caffeic Acid | C9H8O4 | CID 689043 - PubChem (n.d.).\u00a0 https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/689043. Accessed 5 Aug 2026"},{"key":"6004_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5371\/HP.2024.36.1.1","volume":"36","author":"Y Cha","year":"2024","unstructured":"Cha Y, Lee J, Choy W, Lee JS, Lee HH, Chae DS (2024) Pathophysiology and treatment of gout arthritis; including gout arthritis of hip joint: a literature review. Hip Pelvis 36:1. https:\/\/doi.org\/10.5371\/HP.2024.36.1.1","journal-title":"Hip Pelvis"},{"key":"6004_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-020-59451-Z","volume":"10","author":"J Chen","year":"2020","unstructured":"Chen J, Yang J, Ma L, Li J, Shahzad N, Kim CK (2020) Structure-antioxidant activity relationship of methoxy, phenolic hydroxyl, and carboxylic acid groups of phenolic acids. Sci Rep 10:2611. https:\/\/doi.org\/10.1038\/S41598-020-59451-Z","journal-title":"Sci Rep"},{"key":"6004_CR16","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2174\/1389201024666230621141014\/CITE\/REFWORKS","volume":"25","author":"J Chen","year":"2023","unstructured":"Chen J, Yu S, He Z, Zhu D, Cai X, Ruan Z et al (2023) Inhibition of xanthine oxidase by 4-nitrocinnamic acid: in vitro and in vivo investigations and docking simulations. Curr Pharm Biotechnol 25:477\u2013487. https:\/\/doi.org\/10.2174\/1389201024666230621141014\/CITE\/REFWORKS","journal-title":"Curr Pharm Biotechnol"},{"key":"6004_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/J.BMCL.2024.130036","volume":"116","author":"P Chen","year":"2025","unstructured":"Chen P, Chen P, Wang X (2025) Design, synthesis and bioactivity evaluation of cinnamic acid derivatives as potential anti-inflammatory agents against LPS-induced acute lung injury. Bioorg Med Chem Lett 116:130036. https:\/\/doi.org\/10.1016\/J.BMCL.2024.130036","journal-title":"Bioorg Med Chem Lett"},{"key":"6004_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/FOODS12244465","volume":"12","author":"Y Chen","year":"2023","unstructured":"Chen Y, Yang J, Rao Q, Wang C, Chen X, Zhang Y et al (2023) Understanding hyperuricemia: pathogenesis, potential therapeutic role of bioactive peptides, and assessing bioactive peptide advantages and challenges. Foods 12:4465. https:\/\/doi.org\/10.3390\/FOODS12244465","journal-title":"Foods"},{"key":"6004_CR19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/S40001-024-02012-1","volume":"29","author":"Z Chen","year":"2024","unstructured":"Chen Z, Xue X, Ma L, Zhou S, Li K, Wang C et al (2024) Effect of low-purine diet on the serum uric acid of gout patients in different clinical subtypes: a prospective cohort study. Eur J Med Res 29:449. https:\/\/doi.org\/10.1186\/S40001-024-02012-1","journal-title":"Eur J Med Res"},{"key":"6004_CR20","doi-asserted-by":"publisher","first-page":"1186161","DOI":"10.3389\/FNUT.2023.1186161\/FULL","volume":"10","author":"W Cheng-yuan","year":"2023","unstructured":"Cheng-yuan W, Jian-gang D (2023) Research progress on the prevention and treatment of hyperuricemia by medicinal and edible plants and its bioactive components. Front Nutr 10:1186161. https:\/\/doi.org\/10.3389\/FNUT.2023.1186161\/FULL","journal-title":"Front Nutr"},{"key":"6004_CR21","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/J.FOODCHEM.2006.11.012","volume":"104","author":"JC Cheng","year":"2007","unstructured":"Cheng JC, Dai F, Zhou B, Yang L, Liu ZL (2007) Antioxidant activity of hydroxycinnamic acid derivatives in human low density lipoprotein: mechanism and structure\u2013activity relationship. Food Chem 104:132\u2013139. https:\/\/doi.org\/10.1016\/J.FOODCHEM.2006.11.012","journal-title":"Food Chem"},{"key":"6004_CR22","doi-asserted-by":"publisher","DOI":"10.5049\/EBP.2021.19.1.1","volume":"19","author":"S Chung","year":"2021","unstructured":"Chung S, Kim GH (2021) Urate transporters in the kidney: what clinicians need to know. Electrolytes Blood Press 19:1. https:\/\/doi.org\/10.5049\/EBP.2021.19.1.1","journal-title":"Electrolytes & Blood Pressure"},{"key":"6004_CR23","unstructured":"Chlorogenic Acid | C16H18O9 | CID 1794427 - PubChem (n.d.).\u00a0\nhttps:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/1794427. Accessed 5 Aug 2026"},{"key":"6004_CR24","unstructured":"Cinnamic Acid | C9H8O2 | CID 444539 - PubChem (n.d.).\u00a0 https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/444539. Accessed 5 Aug 2026"},{"key":"6004_CR25","doi-asserted-by":"publisher","first-page":"e507","DOI":"10.1016\/S2665-9913(24)00117-6","volume":"6","author":"M Cross","year":"2024","unstructured":"Cross M, Ong KL, Culbreth GT, Steinmetz JD, Cousin E, Lenox H et al (2024) Global, regional, and national burden of gout, 1990\u20132020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol 6:e507\u2013e517. https:\/\/doi.org\/10.1016\/S2665-9913(24)00117-6","journal-title":"Lancet Rheumatol"},{"key":"6004_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/APP112110306","volume":"11","author":"H Dai","year":"2021","unstructured":"Dai H, Lv S, Fu X, Li W (2021) Identification of scopoletin and chlorogenic acid as potential active components in sunflower calathide enzymatically hydrolyzed extract towards hyperuricemia. Appl Sci (Basel) 11:10306. https:\/\/doi.org\/10.3390\/APP112110306","journal-title":"Appl Sci (Basel)"},{"key":"6004_CR27","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"N Dalbeth","year":"2021","unstructured":"Dalbeth N, Gosling AL, Gaffo A, Abhishek A (2021) Gout. Lancet 397:1843\u20131855. https:\/\/doi.org\/10.1016\/S0140-6736(21)00569-9","journal-title":"Lancet"},{"issue":"1","key":"6004_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/S11655-022-3720-7","volume":"29","author":"W Dang","year":"2022","unstructured":"Dang W, Xu D, Zhou J (2022) Effect of berberine on activation of TLR4-NF\u03baB signaling pathway and NLRP3 inflammasome in patients with gout. Chin J Integr Med 29(1):10\u201318. https:\/\/doi.org\/10.1007\/S11655-022-3720-7","journal-title":"Chin J Integr Med"},{"key":"6004_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/J.BERH.2021.101723","volume":"35","author":"A Danve","year":"2021","unstructured":"Danve A, Sehra ST, Neogi T (2021) Role of diet in hyperuricemia and gout. Best Pract Res Clin Rheumatol 35:101723. https:\/\/doi.org\/10.1016\/J.BERH.2021.101723","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"6004_CR30","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.2147\/TCRM.S552281","volume":"21","author":"C Dewi","year":"2025","unstructured":"Dewi C, Puspita F, Insani WN, Sinuraya RK, Puspitasari IM, Zakiyah N (2025) Hepatic safety of febuxostat and allopurinol in gout patients: an updated systematic review and meta-analysis of randomized controlled trials. Ther Clin Risk Manag 21:1747. https:\/\/doi.org\/10.2147\/TCRM.S552281","journal-title":"Ther Clin Risk Manag"},{"key":"6004_CR31","doi-asserted-by":"publisher","first-page":"439","DOI":"10.34172\/jhp.2024.49420","volume":"13","author":"T Dhammaraj","year":"2024","unstructured":"Dhammaraj T, Kotseekieo P, Chotikarn T, Phosrithong N, Praison W, Prasomsub T et al (2024) In vitro investigation of xanthine oxidase inhibitory and antioxidant activities of 3, 4, 5-trihydroxycinnamic acid. J Herbmed Pharmacol 13:439\u201349. https:\/\/doi.org\/10.34172\/jhp.2024.49420","journal-title":"J Herbmed Pharmacol"},{"key":"6004_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/NU14183709","volume":"14","author":"S Di Giacomo","year":"2022","unstructured":"Di Giacomo S, Percaccio E, Gull\u00ec M, Romano A, Vitalone A, Mazzanti G et al (2022) Recent advances in the neuroprotective properties of ferulic acid in Alzheimer\u2019s disease: a narrative review. Nutrients 14:3709. https:\/\/doi.org\/10.3390\/NU14183709","journal-title":"Nutrients"},{"key":"6004_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01916-y","author":"L Du","year":"2024","unstructured":"Du L, Zong Y, Li H, Wang Q, Xie L, Yang B et al (2024) Hyperuricemia and its related diseases: mechanisms and advances in therapy. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-024-01916-y","journal-title":"Signal Transduct Target Ther"},{"key":"6004_CR34","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.clinthera.2025.03.009","volume":"47","author":"X Fan","year":"2025","unstructured":"Fan X, Wang R (2025) Drug-related gastric perforation secondary to prolonged febuxostat administration: a case report. Clin Ther 47:522\u2013525. https:\/\/doi.org\/10.1016\/j.clinthera.2025.03.009","journal-title":"Clin Ther"},{"key":"6004_CR35","unstructured":"FDA adds Boxed Warning for increased risk of death with gout medicine Uloric (febuxostat) | FDA (n.d.). https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-adds-boxed-warning-increased-risk-death-gout-medicine-uloric-febuxostat. Accessed 2 Feb 2026"},{"key":"6004_CR36","doi-asserted-by":"crossref","unstructured":"Feng S, Wu S, Xie F, Yang CS, Shao P (2022) Natural compounds lower uric acid levels and hyperuricemia: molecular mechanisms and prospective. Trends Food Sci Technol. Elsevier","DOI":"10.1016\/j.tifs.2022.03.002"},{"key":"6004_CR37","unstructured":"Ferulic Acid | C10H10O4 | CID 445858 - PubChem (n.d.).\u00a0\nhttps:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/445858. Accessed 5 Aug 2026"},{"key":"6004_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/J.FOODCHEM.2024.140080","volume":"459","author":"M Freitas","year":"2024","unstructured":"Freitas M, Ribeiro D, Janela JS, Varela CL, Costa SC, da Silva ET et al (2024) Plant-derived and dietary phenolic cinnamic acid derivatives: anti-inflammatory properties. Food Chem 459:140080. https:\/\/doi.org\/10.1016\/J.FOODCHEM.2024.140080","journal-title":"Food Chem"},{"key":"6004_CR39","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/ACR.24180","volume":"72","author":"JD FitzGerald","year":"2020","unstructured":"FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM et al (2020) 2020 American College of Rheumatology Guideline for the management of gout. Arthritis Care Res (Hoboken) 72:744\u2013760. https:\/\/doi.org\/10.1002\/ACR.24180","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6004_CR40","doi-asserted-by":"publisher","first-page":"6098","DOI":"10.3390\/MA14206098\/S1","volume":"14","author":"K Gryko","year":"2021","unstructured":"Gryko K, Kalinowska M, Ofman P, Choi\u0144ska R, \u015awiderski G, \u015awis\u0142ocka R et al (2021) Natural cinnamic acid derivatives: a comprehensive study on structural, anti\/pro-oxidant, and environmental impacts. Materials 14:6098. https:\/\/doi.org\/10.3390\/MA14206098\/S1","journal-title":"Materials"},{"key":"6004_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113139","volume":"42","author":"H Gu","year":"2023","unstructured":"Gu H, Yu H, Qin L, Yu H, Song Y, Chen G et al (2023) MSU crystal deposition contributes to inflammation and immune responses in gout remission. Cell Rep 42:113139. https:\/\/doi.org\/10.1016\/j.celrep.2023.113139","journal-title":"Cell Rep"},{"key":"6004_CR42","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1080\/01480545.2021.1993703","volume":"45","author":"IN Hakyemez","year":"2022","unstructured":"Hakyemez IN, Cevizci MN, Aksoz E, Yilmaz K, Uysal S, Altun E (2022) Protective effects of p-coumaric acid against gentamicin-induced nephrotoxicity in rats. Drug Chem Toxicol 45:2825\u20132832. https:\/\/doi.org\/10.1080\/01480545.2021.1993703","journal-title":"Drug Chem Toxicol"},{"key":"6004_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/S12967-023-04307-Z","author":"Y Han","year":"2023","unstructured":"Han Y, Cao Y, Han X, Di H, Yin Y, Wu J et al (2023) Hyperuricemia and gout increased the risk of long-term mortality in patients with heart failure: insights from the National Health and Nutrition Examination Survey. J Transl Med. https:\/\/doi.org\/10.1186\/S12967-023-04307-Z","journal-title":"J Transl Med"},{"key":"6004_CR44","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/JSFA.10675","volume":"101","author":"X He","year":"2021","unstructured":"He X, Zheng S, Sheng Y, Miao T, Xu J, Xu W et al (2021) Chlorogenic acid ameliorates obesity by preventing energy balance shift in high-fat diet induced obese mice. J Sci Food Agric 101:631\u2013637. https:\/\/doi.org\/10.1002\/JSFA.10675","journal-title":"J Sci Food Agric"},{"key":"6004_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28041921","volume":"28","author":"R Hille","year":"2023","unstructured":"Hille R (2023) Xanthine oxidase\u2014a personal history. Molecules 28:1921. https:\/\/doi.org\/10.3390\/molecules28041921","journal-title":"Molecules"},{"key":"6004_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/J.JNUTBIO.2025.110241","volume":"150","author":"C Hu","year":"2026","unstructured":"Hu C, Dong C, Yang H, Yu Z, Li Y, Qiu Y et al (2026) Diosmetin alleviates hyperuricemic nephropathy by activating the BNIP3\/Nrf2\/GPX4 pathway to inhibit ferroptosis of renal tubular epithelial cells induced by monosodium urate crystals. J Nutr Biochem 150:110241. https:\/\/doi.org\/10.1016\/J.JNUTBIO.2025.110241","journal-title":"J Nutr Biochem"},{"key":"6004_CR47","doi-asserted-by":"publisher","first-page":"1218015","DOI":"10.3389\/FPHAR.2023.1218015\/BIBTEX","volume":"14","author":"J Huang","year":"2023","unstructured":"Huang J, Xie M, He L, Song X, Cao T (2023) Chlorogenic acid: a review on its mechanisms of anti-inflammation, disease treatment, and related delivery systems. Front Pharmacol 14:1218015. https:\/\/doi.org\/10.3389\/FPHAR.2023.1218015\/BIBTEX","journal-title":"Front Pharmacol"},{"key":"6004_CR48","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.biopha.2018.07.161","volume":"107","author":"X Huang","year":"2018","unstructured":"Huang X, Xi Y, Pan Q, Mao Z, Zhang R, Ma X et al (2018) Caffeic acid protects against IL-1\u03b2-induced inflammatory responses and cartilage degradation in articular chondrocytes. Biomed Pharmacother 107:433\u2013439. https:\/\/doi.org\/10.1016\/j.biopha.2018.07.161","journal-title":"Biomed Pharmacother"},{"key":"6004_CR49","doi-asserted-by":"publisher","unstructured":"Ishaq M, Zhao L, Soliman MM, Althobaiti S, Al-Harthi HF, Albattal SB et al (2024) Ameliorative impacts of sinapic acid against monosodium urate crystal-induced gouty arthritis and inflammation through different signaling pathways. Toxicol Res (Camb) 13. \nhttps:\/\/doi.org\/10.1093\/TOXRES\/TFAE130","DOI":"10.1093\/TOXRES\/TFAE130"},{"key":"6004_CR50","first-page":"165","volume":"14","author":"M Karamaae","year":"2005","unstructured":"Karamaae M, Kosi\u00f1ska A, Pegg RB (2005) Comparison of radical-scavenging activities for selected phenolic acids. POLISH JOURNAL OF FOOD AND NUTRITION SCIENCES Pol J Food Nutr Sci 14:165\u2013170","journal-title":"POLISH JOURNAL OF FOOD AND NUTRITION SCIENCES Pol J Food Nutr Sci"},{"key":"6004_CR51","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.2174\/1385272826666221012145959\/CITE\/REFWORKS","volume":"26","author":"J Kaur","year":"2022","unstructured":"Kaur J, Kaur R (2022) p-Coumaric acid: a naturally occurring chemical with potential therapeutic applications. Curr Org Chem 26:1333\u20131349. https:\/\/doi.org\/10.2174\/1385272826666221012145959\/CITE\/REFWORKS","journal-title":"Curr Org Chem"},{"key":"6004_CR52","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/J.SEMARTHRIT.2020.04.007","volume":"50","author":"RT Keenan","year":"2020","unstructured":"Keenan RT (2020) The biology of urate. Semin Arthritis Rheum 50:S2-10. https:\/\/doi.org\/10.1016\/J.SEMARTHRIT.2020.04.007","journal-title":"Semin Arthritis Rheum"},{"key":"6004_CR53","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1021\/ACS.JAFC.0C07579","volume":"69","author":"F Khan","year":"2021","unstructured":"Khan F, Bamunuarachchi NI, Tabassum N, Kim YM (2021) Caffeic acid and its derivatives: antimicrobial drugs toward microbial pathogens. J Agric Food Chem 69:2979\u20133004. https:\/\/doi.org\/10.1021\/ACS.JAFC.0C07579","journal-title":"J Agric Food Chem"},{"key":"6004_CR54","doi-asserted-by":"publisher","first-page":"140","DOI":"10.4078\/jrd.2022.29.3.140","volume":"29","author":"SK Kim","year":"2022","unstructured":"Kim SK (2022) The mechanism of the NLRP3 inflammasome activation and pathogenic implication in the pathogenesis of gout. J Rheum Dis 29:140\u2013153. https:\/\/doi.org\/10.4078\/jrd.2022.29.3.140","journal-title":"J Rheum Dis"},{"key":"6004_CR55","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/J.JTEMB.2019.08.012","volume":"56","author":"MM Kiyani","year":"2019","unstructured":"Kiyani MM, Butt MA, Rehman H, Ali H, Hussain SA, Obaid S et al (2019) Antioxidant and anti-gout effects of orally administered zinc oxide nanoparticles in gouty mice. J Trace Elem Med Biol 56:169\u2013177. https:\/\/doi.org\/10.1016\/J.JTEMB.2019.08.012","journal-title":"J Trace Elem Med Biol"},{"key":"6004_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13075-022-02933-4\/FIGURES\/5","volume":"24","author":"B Lai","year":"2022","unstructured":"Lai B, Yu HP, Chang YJ, Wang LC, Chen CK, Zhang W et al (2022) Assessing the causal relationships between gout and hypertension: a bidirectional Mendelian randomisation study with coarsened exposures. Arthritis Res Ther 24:1\u201312. https:\/\/doi.org\/10.1186\/S13075-022-02933-4\/FIGURES\/5","journal-title":"Arthritis Res Ther"},{"key":"6004_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.861399","author":"JH Lee","year":"2022","unstructured":"Lee JH, Kim HS, Lee JH, Yang G, Kim HJ (2022) Natural products as a novel therapeutic strategy for NLRP3 inflammasome-mediated gout. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.861399","journal-title":"Front Pharmacol"},{"key":"6004_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/J.REDOX.2021.102108","volume":"46","author":"TS Lee","year":"2021","unstructured":"Lee TS, Lu TM, Chen CH, Guo BC, Hsu CP (2021) Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine\/dimethylarginine dimethylaminotransferase 2 pathway. Redox Biol 46:102108. https:\/\/doi.org\/10.1016\/J.REDOX.2021.102108","journal-title":"Redox Biol"},{"key":"6004_CR59","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/FSH3.12027","volume":"2","author":"J Li","year":"2024","unstructured":"Li J, Liu W, Jiao W, Lian Y, Mi S, Chitrakar B et al (2024) Effect of ferulic acid and p-coumaric acid on lowering uric acid through network pharmacology and in vitro studies. Food Sci Health 2:133\u2013144. https:\/\/doi.org\/10.1002\/FSH3.12027","journal-title":"Food Sci Health"},{"key":"6004_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29184468","volume":"29","author":"K Li","year":"2024","unstructured":"Li K, Xu R, Kuang M, Ma W, Li N (2024) Bioassay-guided isolation and identification of xanthine oxidase inhibitory constituents from the fruits of Chaenomeles speciosa (Sweet) Nakai. Molecules 29:4468. https:\/\/doi.org\/10.3390\/molecules29184468","journal-title":"Molecules"},{"key":"6004_CR61","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2024.2438847","author":"X Li","year":"2024","unstructured":"Li X, Gu Y, Ling Y, Wang M, Miao J, Xue L et al (2024) Association between mitophagy and NLRP3 inflammasome in uric acid nephropathy. Ren Fail. https:\/\/doi.org\/10.1080\/0886022X.2024.2438847","journal-title":"Ren Fail"},{"key":"6004_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176528","author":"Y Li","year":"2024","unstructured":"Li Y, Zheng F, Zhong S, Zhao K, Liao H, Liang J et al (2024) Protecting against ferroptosis in hyperuricemic nephropathy: the potential of ferrostatin-1 and its inhibitory effect on URAT1. Eur J Pharmacol. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176528","journal-title":"Eur J Pharmacol"},{"key":"6004_CR63","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.1111\/IJFS.16617","volume":"58","author":"Z Li","year":"2023","unstructured":"Li Z, Niu L, Chen Y, Qiu X, Du T, Zhu M et al (2023) Recent advance in the biological activity of chlorogenic acid and its application in food industry. Int J Food Sci Technol 58:4931\u20134947. https:\/\/doi.org\/10.1111\/IJFS.16617","journal-title":"Int J Food Sci Technol"},{"key":"6004_CR64","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.phymed.2018.02.002","volume":"41","author":"Y Lin","year":"2018","unstructured":"Lin Y, Liu PG, Liang WQ, Hu YJ, Xu P, Zhou J et al (2018) Luteolin-4\u2032-O-glucoside and its aglycone, two major flavones of Gnaphalium affine D. Don, resist hyperuricemia and acute gouty arthritis activity in animal models. Phytomedicine 41:54\u201361. https:\/\/doi.org\/10.1016\/j.phymed.2018.02.002","journal-title":"Phytomedicine"},{"key":"6004_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/PH17111507","author":"Z Lin","year":"2024","unstructured":"Lin Z, Gupta JK, Maqbool M, Kumar K, Sharma A, Wahi N (2024) The therapeutic management of chemical and herbal medications on uric acid levels and gout: modern and traditional wisdom. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/PH17111507","journal-title":"Pharmaceuticals (Basel)"},{"key":"6004_CR66","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3892\/mmr.2024.13256","volume":"30","author":"F Liu","year":"2024","unstructured":"Liu F, Bai Y, Wan Y, He J, Li Q, Xie Y et al (2024) Mechanism of flavonoids in the treatment of gouty arthritis (review). Mol Med Rep 30:132\u20132024. https:\/\/doi.org\/10.3892\/mmr.2024.13256","journal-title":"Mol Med Rep"},{"key":"6004_CR67","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/HM9.0000000000000016","volume":"2","author":"L Liu","year":"2022","unstructured":"Liu L, Wang D, Liu M, Yu H, Chen Q, Wu Y et al (2022) The development from hyperuricemia to gout: key mechanisms and natural products for treatment. Acupunct Herb Med 2:25\u201332. https:\/\/doi.org\/10.1097\/HM9.0000000000000016","journal-title":"Acupuncture and Herbal Medicine"},{"key":"6004_CR68","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/1470380","volume":"2021","author":"N Liu","year":"2021","unstructured":"Liu N, Xu H, Sun Q, Yu X, Chen W, Wei H et al (2021) The role of oxidative stress in hyperuricemia and xanthine oxidoreductase (XOR) inhibitors. Oxid Med Cell Longev 2021:1470380. https:\/\/doi.org\/10.1155\/2021\/1470380","journal-title":"Oxid Med Cell Longev"},{"key":"6004_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJBIOMAC.2023.126542","volume":"253","author":"Y Lou","year":"2023","unstructured":"Lou Y, Gao Q, Fan M, Waleed AA, Wang L, Li Y et al (2023) Ferulic acid ameliorates hyperuricemia by regulating xanthine oxidase. Int J Biol Macromol 253:126542. https:\/\/doi.org\/10.1016\/J.IJBIOMAC.2023.126542","journal-title":"Int J Biol Macromol"},{"key":"6004_CR70","doi-asserted-by":"publisher","DOI":"10.1007\/S10787-025-01784-0","author":"SSA Mageed","year":"2025","unstructured":"Mageed SSA, Mohamed FA, Sobhy M, Elosaily AH, El-Dessouki AM, Ghaiad HR et al (2025) Integrating natural products with modern medicine in the treatment of gouty arthritis: a review. Springer. https:\/\/doi.org\/10.1007\/S10787-025-01784-0","journal-title":"Springer"},{"key":"6004_CR71","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3949\/CCJM.92B.06025","volume":"92","author":"BF Mandell","year":"2025","unstructured":"Mandell BF (2025) Allopurinol hypersensitivity is rare, bad, and partially avoidable, but allopurinol can still be used effectively. Cleve Clin J Med 92:326\u2013328. https:\/\/doi.org\/10.3949\/CCJM.92B.06025","journal-title":"Cleve Clin J Med"},{"key":"6004_CR72","doi-asserted-by":"publisher","first-page":"6874","DOI":"10.3390\/MOLECULES27206874\/S1","volume":"27","author":"S Mastoor","year":"2022","unstructured":"Mastoor S, Nazim F, Rizwan-ul-Hasan S, Ahmed K, Khan S, Ali SN et al (2022) Analysis of the antimicrobial and anti-biofilm activity of natural compounds and their analogues against Staphylococcus aureus isolates. Molecules 27:6874. https:\/\/doi.org\/10.3390\/MOLECULES27206874\/S1","journal-title":"Molecules"},{"key":"6004_CR73","unstructured":"Mazumder R, Jaiswal A, Sharma A (n.d.) Natural bioactives in the management of hyperuricemia: a challenge to gout therapy. Int J Health Sci. AcademiaEdu"},{"key":"6004_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/J.SEMARTHRIT.2022.152150","volume":"58","author":"T McEwan","year":"2023","unstructured":"McEwan T, Bhambra J, Liew DF, Robinson PC (2023) Systematic review of colchicine neuromyopathy: risk factors, duration and resolution. Semin Arthritis Rheum 58:152150. https:\/\/doi.org\/10.1016\/J.SEMARTHRIT.2022.152150","journal-title":"Semin Arthritis Rheum"},{"key":"6004_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/FNUT.2022.966557\/FULL","volume":"9","author":"A Mehmood","year":"2022","unstructured":"Mehmood A, Li J, Rehman AU, Kobun R, Llah IU, Khan I et al (2022) Xanthine oxidase inhibitory study of eight structurally diverse phenolic compounds. Front Nutr 9:966557. https:\/\/doi.org\/10.3389\/FNUT.2022.966557\/FULL","journal-title":"Front Nutr"},{"key":"6004_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2022.911968\/BIBTEX","volume":"13","author":"Y Mei","year":"2022","unstructured":"Mei Y, Dong B, Geng Z, Xu L (2022) Excess uric acid induces gouty nephropathy through crystal formation: a review of recent insights. Front Endocrinol (Lausanne) 13:911968. https:\/\/doi.org\/10.3389\/FENDO.2022.911968\/BIBTEX","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6004_CR77","doi-asserted-by":"publisher","DOI":"10.52361\/fsbh.2021.1.e27","author":"C Na","year":"2021","unstructured":"Na C, Kim HJ, Ahn HS, Shin Y-K, Lee SH (2021) In vitro evidence for inhibitory action of Hydrangea serrata (Thunb.) Ser. leaf extract on urate crystal-induced inflammation. Food Suppl Biomater Health. https:\/\/doi.org\/10.52361\/fsbh.2021.1.e27","journal-title":"Food Supplements and Biomaterials for Health"},{"key":"6004_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29143372","volume":"29","author":"A Narayanankutty","year":"2024","unstructured":"Narayanankutty A, Famurewa AC, Oprea E (2024) Natural bioactive compounds and human health. Molecules 29:3372. https:\/\/doi.org\/10.3390\/molecules29143372","journal-title":"Molecules"},{"key":"6004_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/J.JSPS.2024.101980","volume":"32","author":"DK Nguyen","year":"2024","unstructured":"Nguyen DK, Liu TW, Hsu SJ, Huynh QDT, Thi Duong TL, Chu MH et al (2024) Xanthine oxidase inhibition study of isolated secondary metabolites from Dolichandrone spathacea (Bignoniaceae): in vitro and in silico approach. Saudi Pharm J 32:101980. https:\/\/doi.org\/10.1016\/J.JSPS.2024.101980","journal-title":"Saudi Pharm J"},{"key":"6004_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/NU16070924","volume":"16","author":"V Nguyen","year":"2024","unstructured":"Nguyen V, Taine EG, Meng D, Cui T, Tan W (2024) Chlorogenic acid: a systematic review on the biological functions, mechanistic actions, and therapeutic potentials. Nutrients 16:924. https:\/\/doi.org\/10.3390\/NU16070924","journal-title":"Nutrients"},{"issue":"1","key":"6004_CR81","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41598-022-26519-x","volume":"13","author":"Y Ohashi","year":"2023","unstructured":"Ohashi Y, Toyoda M, Saito N, Koizumi M, Kanai G, Komaba H et al (2023) Evaluation of ABCG2-mediated extra-renal urate excretion in hemodialysis patients. Sci Rep 13(1):93. https:\/\/doi.org\/10.1038\/s41598-022-26519-x","journal-title":"Sci Rep"},{"key":"6004_CR82","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1016\/j.ijbiomac.2020.07.297","volume":"162","author":"R Ou","year":"2020","unstructured":"Ou R, Lin L, Zhao M, Xie Z (2020) Action mechanisms and interaction of two key xanthine oxidase inhibitors in galangal: combination of in vitro and in silico molecular docking studies. Int J Biol Macromol 162:1526\u20131535. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.07.297","journal-title":"Int J Biol Macromol"},{"key":"6004_CR83","unstructured":"P-Coumaric Acid | C9H8O3 | CID 637542 - PubChem (n.d.).\u00a0 https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/637542. Accessed 5 Aug 2026"},{"issue":"4","key":"6004_CR84","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1007\/S11033-021-06367-0","volume":"48","author":"A Pandi","year":"2021","unstructured":"Pandi A, Kalappan VM (2021) Pharmacological and therapeutic applications of sinapic acid\u2014an updated review. Mol Biol Rep 48(4):3733\u201345. https:\/\/doi.org\/10.1007\/S11033-021-06367-0","journal-title":"Mol Biol Rep"},{"key":"6004_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/NU12123794","author":"YH Park","year":"2020","unstructured":"Park YH, Kim DH, Lee JS, Jeong HI, Lee KW, Kang TH (2020) A 12-week, multicenter, randomized, double-blind, placebo-controlled clinical trial for evaluation of the efficacy and safety of DKB114 on reduction of uric acid in serum. Nutrients. https:\/\/doi.org\/10.3390\/NU12123794","journal-title":"Nutrients"},{"key":"6004_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2025.1660890","volume":"16","author":"Z Peng","year":"2025","unstructured":"Peng Z, Meng F, Deng Q, Huang Y, Mao D, Long Y et al (2025) Advances in drug delivery systems for the management of gout and hyperuricemia. Front Pharmacol 16:1660890. https:\/\/doi.org\/10.3389\/FPHAR.2025.1660890","journal-title":"Front Pharmacol"},{"key":"6004_CR87","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/S00011-013-0602-7\/METRICS","volume":"62","author":"SJ Pragasam","year":"2013","unstructured":"Pragasam SJ, Rasool M (2013) Dietary component p-coumaric acid suppresses monosodium urate crystal-induced inflammation in rats. Inflamm Res 62:489\u2013498. https:\/\/doi.org\/10.1007\/S00011-013-0602-7\/METRICS","journal-title":"Inflamm Res"},{"key":"6004_CR88","unstructured":"Qurie A, Preuss CV, Musa R (2023) Allopurinol. StatPearls 2023. https:\/\/pubmed.ncbi.nlm.nih.gov\/29763117\/"},{"key":"6004_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2021.622815\/TEXT","volume":"12","author":"M Raish","year":"2021","unstructured":"Raish M, Shahid M, Bin Jardan YA, Ansari MA, Alkharfy KM, Ahad A et al (2021) Gastroprotective effect of sinapic acid on ethanol-induced gastric ulcers in rats: involvement of Nrf2\/HO-1 and NF-\u03baB signaling and antiapoptotic role. Front Pharmacol 12:622815. https:\/\/doi.org\/10.3389\/FPHAR.2021.622815\/TEXT","journal-title":"Front Pharmacol"},{"key":"6004_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/ANTIOX10081205","volume":"10","author":"S Roychoudhury","year":"2021","unstructured":"Roychoudhury S, Sinha B, Choudhury BP, Jha NK, Palit P, Kundu S et al (2021) Scavenging properties of plant-derived natural biomolecule para-coumaric acid in the prevention of oxidative stress-induced diseases. Antioxidants (Basel) 10:1205. https:\/\/doi.org\/10.3390\/ANTIOX10081205","journal-title":"Antioxidants (Basel)"},{"key":"6004_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/J.FOODCHEM.2022.134349","volume":"403","author":"M Sabolov\u00e1","year":"2023","unstructured":"Sabolov\u00e1 M, Kulma M, Pet\u0159\u00ed\u010dkov\u00e1 D, Klete\u010dkov\u00e1 K, Kou\u0159imsk\u00e1 L (2023) Changes in purine and uric acid content in edible insects during culinary processing. Food Chem 403:134349. https:\/\/doi.org\/10.1016\/J.FOODCHEM.2022.134349","journal-title":"Food Chem"},{"key":"6004_CR92","doi-asserted-by":"publisher","unstructured":"Sadiq NM, Robinson KJ, Terrell JM (2025) Colchicine. Encyclopedia of toxicology, 4th edn. Volume 1\u20139;3:V3\u2013165-V3\u2013168. \nhttps:\/\/doi.org\/10.1016\/B978-0-12-824315-2.00498-X","DOI":"10.1016\/B978-0-12-824315-2.00498-X"},{"key":"6004_CR93","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/JPP\/RGAC021","volume":"74","author":"VF Salau","year":"2022","unstructured":"Salau VF, Erukainure OL, Ijomone OM, Islam MS (2022) Caffeic acid regulates glucose homeostasis and inhibits purinergic and cholinergic activities while abating oxidative stress and dyslipidaemia in fructose-streptozotocin-induced diabetic rats. J Pharm Pharmacol 74:973\u2013984. https:\/\/doi.org\/10.1093\/JPP\/RGAC021","journal-title":"J Pharm Pharmacol"},{"key":"6004_CR94","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/FCP.12860","volume":"37","author":"VF Salau","year":"2023","unstructured":"Salau VF, Erukainure OL, Olofinsan KO, Bharuth V, Ijomone OM, Islam MS (2023) Ferulic acid improves glucose homeostasis by modulation of key diabetogenic activities and restoration of pancreatic architecture in diabetic rats. Fundam Clin Pharmacol 37:324\u2013339. https:\/\/doi.org\/10.1111\/FCP.12860","journal-title":"Fundam Clin Pharmacol"},{"key":"6004_CR95","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/JPS.3030481215","volume":"48","author":"HW Schultz","year":"1959","unstructured":"Schultz HW, Wiese GA (1959) The synthesis of some derivatives of cinnamic acid and their antifungal action. J Am Pharm Assoc Am Pharm Assoc (Baltim) 48:750\u2013752. https:\/\/doi.org\/10.1002\/JPS.3030481215","journal-title":"J Am Pharm Assoc Am Pharm Assoc (Baltim)"},{"key":"6004_CR96","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/J.SAJB.2023.03.046","volume":"157","author":"M Secme","year":"2023","unstructured":"Secme M, Mutlu D, Elmas L, Arslan S (2023) Assessing effects of caffeic acid on cytotoxicity, apoptosis, invasion, GST enzyme activity, oxidant, antioxidant status and micro-RNA expressions in HCT116 colorectal cancer cells. S Afr J Bot 157:19\u201326. https:\/\/doi.org\/10.1016\/J.SAJB.2023.03.046","journal-title":"S Afr J Bot"},{"key":"6004_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105189","volume":"299","author":"M Sekine","year":"2023","unstructured":"Sekine M, Okamoto K, Pai EF, Nagata K, Ichida K, Hille R et al (2023) Allopurinol and oxypurinol differ in their strength and mechanisms of inhibition of xanthine oxidoreductase. J Biol Chem 299:105189. https:\/\/doi.org\/10.1016\/j.jbc.2023.105189","journal-title":"J Biol Chem"},{"key":"6004_CR98","unstructured":"Sinapic acid | C11H12O5 | CID 10743 - PubChem (n.d.).\u00a0 https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/10743. Accessed 5 Aug 2026"},{"key":"6004_CR99","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1039\/d4md00072b","volume":"15","author":"A Singh","year":"2018","unstructured":"Singh A, Debnath R, Chawla V, Chawla PA (2018) Heterocyclic compounds as xanthine oxidase inhibitors for the management of hyperuricemia: synthetic strategies, structure\u2013activity relationship and molecular docking studies (2018\u20132024). RSC Med Chem 15:1849\u20131876. https:\/\/doi.org\/10.1039\/d4md00072b","journal-title":"RSC Med Chem"},{"key":"6004_CR100","doi-asserted-by":"crossref","unstructured":"Singh J, Gaffo A (2020) Gout epidemiology and comorbidities. Semin Arthritis Rheum. Elsevier","DOI":"10.1016\/j.semarthrit.2020.04.008"},{"key":"6004_CR101","doi-asserted-by":"publisher","first-page":"312","DOI":"10.5114\/REUM.2020.100140","volume":"58","author":"M Skoczy\u0144ska","year":"2020","unstructured":"Skoczy\u0144ska M, Chowaniec M, Szymczak A, Langner-Hetma\u0144czuk A, Maci\u0105\u017cek-Chyra B, Wiland P (2020) Pathophysiology of hyperuricemia and its clinical significance - a narrative review. Reumatologia 58:312\u2013323. https:\/\/doi.org\/10.5114\/REUM.2020.100140","journal-title":"Reumatologia"},{"key":"6004_CR102","doi-asserted-by":"publisher","first-page":"134","DOI":"10.2478\/JTIM-2022-0031\/ASSET\/GRAPHIC\/J_JTIM-2022-0031_FIG_003.JPG","volume":"10","author":"J Song","year":"2022","unstructured":"Song J, Jin C, Shan Z, Teng W, Li J (2022) Prevalence and risk factors of hyperuricemia and gout: a cross-sectional survey from 31 provinces in mainland China. J Transl Int Med 10:134\u2013145. https:\/\/doi.org\/10.2478\/JTIM-2022-0031\/ASSET\/GRAPHIC\/J_JTIM-2022-0031_FIG_003.JPG","journal-title":"J Transl Int Med"},{"key":"6004_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJPHAR.2021.173929","volume":"897","author":"TN Souza","year":"2021","unstructured":"Souza TN, Santos FM, Alves PR, Ferro JN, Correia ACC, Melo TS et al (2021) Local administration of p-coumaric acid decreases lipopolysaccharide-induced acute lung injury in mice: in vitro and in silico studies. Eur J Pharmacol 897:173929. https:\/\/doi.org\/10.1016\/J.EJPHAR.2021.173929","journal-title":"Eur J Pharmacol"},{"key":"6004_CR104","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3164\/JCBN.40.92","volume":"40","author":"M Srinivasan","year":"2007","unstructured":"Srinivasan M, Sudheer AR, Menon VP (2007) Ferulic acid: therapeutic potential through its antioxidant property. J Clin Biochem Nutr 40:92. https:\/\/doi.org\/10.3164\/JCBN.40.92","journal-title":"J Clin Biochem Nutr"},{"key":"6004_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2021.667753\/FULL","volume":"12","author":"HL Sun","year":"2021","unstructured":"Sun HL, Wu YW, Bian HG, Yang H, Wang H, Meng XM et al (2021) Function of uric acid transporters and their inhibitors in hyperuricaemia. Front Pharmacol 12:667753. https:\/\/doi.org\/10.3389\/FPHAR.2021.667753\/FULL","journal-title":"Front Pharmacol"},{"key":"6004_CR106","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.1002\/JSFA.14341;REQUESTEDJOURNAL:JOURNAL:10970010;WGROUP:STRING:PUBLICATION","volume":"105","author":"J Sun","year":"2025","unstructured":"Sun J, Shen Z, Sun Y, You Y, Zhu C, Cheng S et al (2025) Comparison of the anti-hyperuricemia effects of several cinnamic acid derivatives. J Sci Food Agric 105:6341\u20136347. https:\/\/doi.org\/10.1002\/JSFA.14341;REQUESTEDJOURNAL:JOURNAL:10970010;WGROUP:STRING:PUBLICATION","journal-title":"J Sci Food Agric"},{"key":"6004_CR107","doi-asserted-by":"publisher","unstructured":"Ta\u015ftemur \u015e, Hacis\u00fcleyman L, Karata\u015f \u00d6, Yulak F, Ataseven H (2023) Anticancer activity of sinapic acid by inducing apoptosis in HT-29 human colon cancer cell line. 101:361\u20138. https:\/\/doi.org\/10.1139\/CJPP-2022-0523","DOI":"10.1139\/CJPP-2022-0523"},{"key":"6004_CR108","doi-asserted-by":"publisher","DOI":"10.3390\/PHARMACEUTICS13060899","volume":"13","author":"P T\u00e1trai","year":"2021","unstructured":"T\u00e1trai P, Erd\u0151 F, D\u00f6rnyei G, Krajcsi P (2021) Modulation of urate transport by drugs. Pharmaceutics 13:899. https:\/\/doi.org\/10.3390\/PHARMACEUTICS13060899","journal-title":"Pharmaceutics"},{"key":"6004_CR109","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13247616","author":"J Timsans","year":"2024","unstructured":"Timsans J, Palom\u00e4ki A, Kauppi M (2024) Gout and hyperuricemia: a narrative review of their comorbidities and clinical implications. J Clin Med. https:\/\/doi.org\/10.3390\/jcm13247616","journal-title":"J Clin Med"},{"key":"6004_CR110","unstructured":"trans-4-Nitrocinnamic acid | C9H7NO4 | CID 737157 - PubChem (n.d.).\u00a0 https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/737157. Accessed 5 Aug 2026"},{"key":"6004_CR111","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1080\/00071668.2021.1998365","volume":"63","author":"P Vikrama Chakravarthi","year":"2022","unstructured":"Vikrama Chakravarthi P, Murugesan S, Arivuchelvan A, Sukumar K, Arulmozhi A, Jagadeeswaran A (2022) Therapeutic antigout and antioxidant activity of Piper betle L. in gout-induced broilers. Br Poult Sci 63:324\u201331. https:\/\/doi.org\/10.1080\/00071668.2021.1998365","journal-title":"Br Poult Sci"},{"key":"6004_CR112","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/J.JFF.2019.03.038","volume":"57","author":"Y Wan","year":"2019","unstructured":"Wan Y, Wang F, Zou B, Shen Y, Li Y, Zhang A et al (2019) Molecular mechanism underlying the ability of caffeic acid to decrease uric acid levels in hyperuricemia rats. J Funct Foods 57:150\u2013156. https:\/\/doi.org\/10.1016\/J.JFF.2019.03.038","journal-title":"J Funct Foods"},{"key":"6004_CR113","doi-asserted-by":"publisher","unstructured":"Wang D, Hou J, Wan J, Yang Y, Liu S, Li X et al (2021) Dietary chlorogenic acid ameliorates oxidative stress and improves endothelial function in diabetic mice via Nrf2 activation. J Int Med Res 49. https:\/\/doi.org\/10.1177\/0300060520985363","DOI":"10.1177\/0300060520985363"},{"key":"6004_CR114","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1055\/S-0029-1185521","volume":"75","author":"SH Wang","year":"2009","unstructured":"Wang SH, Chen CS, Huang SH, Yu SH, Lai ZY, Huang ST et al (2009) Hydrophilic ester-bearing chlorogenic acid binds to a novel domain to inhibit xanthine oxidase. Planta Med 75:1237\u20131240. https:\/\/doi.org\/10.1055\/S-0029-1185521","journal-title":"Planta Med"},{"key":"6004_CR115","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/J.IJBIOMAC.2021.06.075","volume":"184","author":"Y Wan","year":"2021","unstructured":"Wan Y, Qian J, Li Y, Shen Y, Chen Y, Fu G et al (2021) Inhibitory mechanism of xanthine oxidase activity by caffeoylquinic acids in vitro. Int J Biol Macromol 184:843\u2013856. https:\/\/doi.org\/10.1016\/J.IJBIOMAC.2021.06.075","journal-title":"Int J Biol Macromol"},{"key":"6004_CR116","doi-asserted-by":"publisher","DOI":"10.1111\/JFBC.14203;WGROUP:STRING:PUBLICATION","volume":"46","author":"K Wang","year":"2022","unstructured":"Wang K, Liang C, Cao W, Luo G, Zhong S, Zeng Z et al (2022) Dietary sinapic acid attenuated high-fat diet-induced lipid metabolism and oxidative stress in male Syrian hamsters. J Food Biochem 46:e14203. https:\/\/doi.org\/10.1111\/JFBC.14203;WGROUP:STRING:PUBLICATION","journal-title":"J Food Biochem"},{"key":"6004_CR117","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1089\/ARS.2024.0672","volume":"43","author":"Q Wang","year":"2025","unstructured":"Wang Q, Xi Y, Zhao H, Xie D, Yu L, Yan Y et al (2025) Ferroptosis mediates the progression of hyperuricemic nephropathy by activating RAGE signaling. Antioxid Redox Signal 43:56\u201374. https:\/\/doi.org\/10.1089\/ARS.2024.0672","journal-title":"Antioxid Redox Signal"},{"key":"6004_CR118","doi-asserted-by":"publisher","DOI":"10.3390\/FOODS14193404","volume":"14","author":"X Wang","year":"2025","unstructured":"Wang X, Su D, Luo X, Chen B, Bhullar KS, Liu H et al (2025) Inhibition of xanthine oxidase by four phenolic acids: kinetic, spectroscopic, molecular simulation, and cellular insights. Foods 14:3404. https:\/\/doi.org\/10.3390\/FOODS14193404","journal-title":"Foods"},{"key":"6004_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/J.BIOPHA.2022.114175","volume":"158","author":"H Wu","year":"2023","unstructured":"Wu H, Wang Y, Huang J, Li Y, Lin Z, Zhang B (2023) Rutin ameliorates gout via reducing XOD activity, inhibiting ROS production and NLRP3 inflammasome activation in quail. Biomed Pharmacother 158:114175. https:\/\/doi.org\/10.1016\/J.BIOPHA.2022.114175","journal-title":"Biomed Pharmacother"},{"key":"6004_CR120","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/COMPOUNDS3010014","volume":"3","author":"Y-C Wu","year":"2023","unstructured":"Wu Y-C, Kuo P-C, Chen W-Y, Tzen JTC, Wu Y-C, Kuo P-C (2023) Reduction of the plasma uric acid level in potassium oxoate-induced hyperuricemic rats by heat-concentrated Prunus mume fruit extract containing three chlorogenic acid isomers. Compounds 3:169\u2013179. https:\/\/doi.org\/10.3390\/COMPOUNDS3010014","journal-title":"Compounds"},{"key":"6004_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/J.FCT.2023.114307","volume":"183","author":"G Xu","year":"2024","unstructured":"Xu G, Wu L, Yang H, Liu T, Tong Y, Wan J et al (2024) Eupatilin inhibits xanthine oxidase in vitro and attenuates hyperuricemia and renal injury in vivo. Food Chem Toxicol 183:114307. https:\/\/doi.org\/10.1016\/J.FCT.2023.114307","journal-title":"Food Chem Toxicol"},{"key":"6004_CR122","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1002\/fft2.287","volume":"4","author":"H Xue","year":"2023","unstructured":"Xue H, Xu M, Gong D, Zhang G (2023) Mechanism of flavonoids inhibiting xanthine oxidase and alleviating hyperuricemia from structure\u2013activity relationship and animal experiments: a review. Food Front 4:1643\u20131665. https:\/\/doi.org\/10.1002\/fft2.287","journal-title":"Food Front"},{"key":"6004_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/J.FBIO.2023.102414","volume":"52","author":"H Yan","year":"2023","unstructured":"Yan H, Meng X, Lin X, Duan N, Wang Z, Wu S (2023) Antifungal activity and inhibitory mechanisms of ferulic acid against the growth of Fusarium graminearum. Food Biosci 52:102414. https:\/\/doi.org\/10.1016\/J.FBIO.2023.102414","journal-title":"Food Biosci"},{"key":"6004_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS22179221","volume":"22","author":"H Yanai","year":"2021","unstructured":"Yanai H, Adachi H, Hakoshima M, Katsuyama H (2021) Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease. Int J Mol Sci 22:9221. https:\/\/doi.org\/10.3390\/IJMS22179221","journal-title":"Int J Mol Sci"},{"key":"6004_CR125","doi-asserted-by":"publisher","first-page":"1026246","DOI":"10.3389\/FPHAR.2022.1026246\/FULL","volume":"13","author":"B Yang","year":"2022","unstructured":"Yang B, Xin M, Liang S, Xu X, Cai T, Dong L et al (2022) New insight into the management of renal excretion and hyperuricemia: potential therapeutic strategies with natural bioactive compounds. Front Pharmacol 13:1026246. https:\/\/doi.org\/10.3389\/FPHAR.2022.1026246\/FULL","journal-title":"Front Pharmacol"},{"key":"6004_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/J.JFF.2025.106722","volume":"127","author":"F Yang","year":"2025","unstructured":"Yang F, Wu Z, Gao J (2025) Sinapic acid alleviates kidney injury of hyperuricemia mice by inhibiting ERK1\/2-mediated apoptosis of renal tubular epithelial cells. J Funct Foods 127:106722. https:\/\/doi.org\/10.1016\/J.JFF.2025.106722","journal-title":"J Funct Foods"},{"key":"6004_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/J.LWT.2021.111411","volume":"146","author":"J Yang","year":"2021","unstructured":"Yang J, Chen J, Hao Y, Liu Y (2021) Identification of the DPPH radical scavenging reaction adducts of ferulic acid and sinapic acid and their structure-antioxidant activity relationship. LWT 146:111411. https:\/\/doi.org\/10.1016\/J.LWT.2021.111411","journal-title":"LWT"},{"key":"6004_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156507","author":"Q Yao","year":"2025","unstructured":"Yao Q, Zhang X, Wang L, Li J, Lv J, Chen J et al (2025) Therapeutic potential of p-coumaric acid in alleviating renal fibrosis through inhibition of M2 macrophage infiltration and cellular communication. Phytomedicine. https:\/\/doi.org\/10.1016\/j.phymed.2025.156507","journal-title":"Phytomedicine"},{"key":"6004_CR129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21608\/RPBS.2025.356216.1351","volume":"9","author":"MB Yasser","year":"2025","unstructured":"Yasser MB, Hagag RS, El-Sayed NM, Hazem RM (2025) Sinapic acid: a brief review of its therapeutic potential and molecular targets in Parkinson\u2019s disease. Rec Pharm Biomed Sci 9:1\u20137. https:\/\/doi.org\/10.21608\/RPBS.2025.356216.1351","journal-title":"Records of Pharmaceutical and Biomedical Sciences"},{"key":"6004_CR130","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/BOR.0000000000000779","volume":"33","author":"C Yokose","year":"2021","unstructured":"Yokose C, McCormick N, Choi HK (2021) The role of diet in hyperuricemia and gout. Curr Opin Rheumatol 33:135. https:\/\/doi.org\/10.1097\/BOR.0000000000000779","journal-title":"Curr Opin Rheumatol"},{"key":"6004_CR131","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4078\/jrd.2024.0054","volume":"32","author":"E Young Ahn","year":"2025","unstructured":"Young Ahn E, Wook So M (2025) The pathogenesis of gout. J Rheum Dis 32:8\u201316. https:\/\/doi.org\/10.4078\/jrd.2024.0054","journal-title":"Journal of Rheumatic Diseases"},{"key":"6004_CR132","unstructured":"Zeiger E, Tice R (1998) Chlorogenic acid [327\u201397\u20139] and caffeic acid [331\u201339\u20135] review of toxicological literature, National Institute of Environmental Health Sciences. Research Triangle Park, NC, USA"},{"key":"6004_CR133","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1039\/D2FO03332A","volume":"14","author":"N Zhang","year":"2023","unstructured":"Zhang N, Zhou J, Zhao L, Zhao Z, Wang S, Zhang L et al (2023) Ferulic acid supplementation alleviates hyperuricemia in high-fructose\/fat diet-fed rats via promoting uric acid excretion and mediating the gut microbiota. Food Funct 14:1710\u20131725. https:\/\/doi.org\/10.1039\/D2FO03332A","journal-title":"Food Funct"},{"key":"6004_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJMECH.2021.114092","volume":"229","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, Liu J, Kuang P, Luo J, Surineni G, Cen X et al (2022) Discovery of novel verinurad analogs as dual inhibitors of URAT1 and GLUT9 with improved druggability for the treatment of hyperuricemia. Eur J Med Chem 229:114092. https:\/\/doi.org\/10.1016\/J.EJMECH.2021.114092","journal-title":"Eur J Med Chem"},{"key":"6004_CR135","doi-asserted-by":"publisher","first-page":"10182","DOI":"10.1021\/ACS.JAFC.2C03099","volume":"70","author":"X Zhou","year":"2022","unstructured":"Zhou X, Zhang B, Zhao X, Lin Y, Zhuang Y, Guo J et al (2022) Chlorogenic acid prevents hyperuricemia nephropathy via regulating TMAO-related gut microbes and inhibiting the PI3K\/AKT\/mTOR pathway. J Agric Food Chem 70:10182\u201310193. https:\/\/doi.org\/10.1021\/ACS.JAFC.2C03099","journal-title":"J Agric Food Chem"},{"key":"6004_CR136","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2022.1060441","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Chen Y, Zhong X, Xia H, Zhao M, Zhao M et al (2022) Lipoxin A4 attenuates MSU-crystal-induced NLRP3 inflammasome activation through suppressing Nrf2 thereby increasing TXNRD2. Front Immunol. https:\/\/doi.org\/10.3389\/FIMMU.2022.1060441","journal-title":"Front Immunol"},{"key":"6004_CR137","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.1039\/D0FO03199B","volume":"12","author":"X Zhou","year":"2021","unstructured":"Zhou X, Zhang B, Zhao X, Lin Y, Wang J, Wang X et al (2021) Chlorogenic acid supplementation ameliorates hyperuricemia, relieves renal inflammation, and modulates intestinal homeostasis. Food Funct 12:5637\u20135649. https:\/\/doi.org\/10.1039\/D0FO03199B","journal-title":"Food Funct"},{"key":"6004_CR138","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3390\/ANTIOX13070853","volume":"13","author":"M Zheng","year":"2024","unstructured":"Zheng M, Liu Y, Zhang G, Yang Z, Xu W, Chen Q (2024) The antioxidant properties, metabolism, application and mechanism of ferulic acid in medicine, food, cosmetics, livestock and poultry. Antioxidants 13:853. https:\/\/doi.org\/10.3390\/ANTIOX13070853","journal-title":"Antioxidants"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-06004-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-06004-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-06004-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:02:55Z","timestamp":1792422175000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-06004-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,19]]},"references-count":138,"alternative-id":["6004"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-06004-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,19]]},"assertion":[{"value":"30 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}